Clinical trials are research studies used to test new ways to prevent, detect, or treat diseases.

They are an important part of how new treatments become available. Before a treatment can be widely used, it needs to be carefully tested to make sure it is safe and works as expected.

Clinical trials follow a step-by-step process. Each stage builds on the previous one, helping researchers understand more about a treatment over time.

For patients, this step-by-step approach helps ensure that treatments are introduced safely and only move forward when there is sufficient evidence to support their use.

Phases of a Trial

Preclinical Research: Foundation for Success

Before a treatment is tested in people, it is studied in laboratories and sometimes in animal models.

This stage helps researchers:

• Understand how the treatment works.

• Identify possible safety concerns.

• Decide whether it is ready to be tested in humans.

Only treatments that show enough potential move forward. According to the National Institutes of Health, this step helps reduce risks before human testing begins.

In practice, this means that many potential treatments are filtered out early, and only a small number reach clinical trials.

For patients, this means that by the time a treatment reaches clinical trials, it has already gone through initial safety checks.

Phase 1: Testing Safety in a Small Group

Phase 1 trials involve a small group of fewer than 100 participants, often healthy volunteers or, in cases like cancer clinical trials, cancer patients. This phase focuses on:

• Identifying safe dosages.

• Monitoring side effects.

• Understanding how the drug interacts with the body.

This stage is essential because it helps researchers understand how the treatment behaves in the body before testing it in larger groups.

At this stage, the main focus is safety, not whether the treatment works for the condition.

Phase 2: Exploring Effectiveness

Phase 2 studies recruit 100–500 participants to evaluate whether the experimental treatment works for specific diseases or conditions. These trials are often randomized to compare the treatment to a control group or standard treatment.

Common questions answered in Phase 2:

• Does the treatment improve the condition?

• Are there unexpected risks or potential benefits?

• What dosage works best for large groups of patients?

This phase also refines protocols for the larger trials to come.

For patients, this is usually the stage where researchers begin to understand whether a treatment may actually help their condition.

Phase 3: Validating for Large-Scale Use

Phase 3 trials involve large numbers of participants, ranging from 300 to 3,000, ensuring the treatment is effective across diverse patient groups. This phase usually involves randomized trials.

Key objectives include:

• Comparing results to a control group or standard treatment (randomization).

• Monitoring long-term side effects.

• Validating findings for regulatory approval.

The results from this phase are used by regulatory authorities to decide whether a treatment can be approved. For example, the U.S. Food and Drug Administration reviews this data before allowing treatments onto the market.

For many patients, this is the stage where treatments begin to look closer to real-world use.

This also means that treatments in Phase 3 have already shown promising results in earlier stages.

Phase 4: Post-Market Monitoring

Once approved, treatments undergo Phase 4 clinical trials to monitor their effectiveness and safety in real-world conditions. These trials often recruit thousands of participants to study long-term impacts and refine dosages for broader populations.

For patients, this stage reflects how a treatment performs in everyday medical practice, beyond controlled study conditions.

Key Features

Clinical trial design ensures that each study generates scientifically valid results. Each trial follows a clinical trial protocol that defines the rules of the study and is submitted to the relevant authority (such as the FDA in the United States) before the trial begins.

A closer look at the elements essential to understanding clinical trials:

• Randomization: Assigns participants to groups to reduce bias.

• Blinding: Prevents participants and researchers from knowing group assignments, maintaining objectivity.

• Control Groups: Compare the experimental drug or treatment against a baseline, such as a placebo.

For instance, a clinical trial protocol might specify:

• Single-blind design: Only participants are unaware of their assignments.

• Double-blind trials: Both participants and researchers (or health care providers) are unaware of groupings.

• Randomized but not blinded trials: Participants know their group assignment but were placed randomly.

What to Expect when Participating

Participating in a clinical trial offers patients access to new treatments while contributing to clinical research. Before joining, review the trial’s informed consent document and consider the following:

• Are you eligible based on the trial’s eligibility criteria?

• Do the potential benefits outweigh the risks?

• Does the study drug align with your health goals?

If you are unsure about eligibility, reviewing the criteria or starting with a pre-screening can help clarify whether a study might be a good fit.

Explore our article on Clinical Trial Eligibility for insights on finding the right trial and navigating the screening process.

In Brief

Clinical trials are essential for advancing medicine, ensuring new drugs, medical treatments, and devices meet rigorous standards for safety and efficacy. From preclinical research to Phase 3 trials and beyond, every trial contributes to better outcomes for future patients.

Whether you’re a participant or a health care provider, understanding the drug development process empowers you to make informed decisions and support innovation in medicine.

Taking the Next Step

If you are considering clinical trials, understanding how they work can make the process feel more manageable.

If you want to explore options that might match your situation, you can start with a short pre-screening.

Start your pre-screening with PatLynk.

At PatLynk, we’re committed to making clinical trials accessible to all. Explore our platform to learn more about clinical trials and to find the right clinical trial for you.